Recruiting NCT06624865
Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Blood and stool sampling.
- Who it may be relevant to
- Registry conditions: Small-intestine Neuroendocrine Tumors. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The aim of the study is to investigate the impact of the microenvironment on tumorigenesis of small intestinal neuroendocrine tumors often located in the terminal ileum, without identified driver mutations.
Interventions
- Other Blood and stool sampling
Blood and stool sampling
Primary outcome measures
- Composition of microbiota [Time frame: At day 1 and month 3]
Eligibility criteria
Inclusion criteria
- Patient with one or more small-intestine neuroendocrine tumor with indication of surgery
- Patient with consent for the collection, storage and reuse of data associated with his/her disease
- Age ≥ 18 years at the time of inclusion
- Non-objection statement obtained for participation in the study
Exclusion criteria
- Patients with poorly differentiated neuroendocrine carcinoma or NET (neuroendocrine tumors) of non-intestinal origin or mixed tumors (MiNEN)
- Pregnant, parturient or breast-feeding women
- Minors
- Persons deprived of liberty by judicial or administrative decision
- Adults under legal protection (guardianship, curatorship)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Edouard Herriot University Hospital — Lyon
Identifiers
NCT: NCT06624865 · 69HCL23_1290 · 2023-A02667-38